TMCnet News

Human Embryonic Stem Cell (HESC) Research - Global Strategic Business Report - Research and Markets
[March 24, 2017]

Human Embryonic Stem Cell (HESC) Research - Global Strategic Business Report - Research and Markets


Research and Markets has announced the addition of the "Human Embryonic Stem Cell (hESC) Research - Global Strategic Business Report" report to their offering.

This report analyzes the Global market for Human Embryonic Stem Cell (hESC) Research in US$ Million. Annual estimates and forecasts are provided for the period 2014 through 2022. Market data and analytics are derived from primary and secondary research.

The report profiles 25 companies including many key and niche players such as

  • Astellas Institute of Regenerative Medicine (US)
  • Asterias Biotherapeutics, Inc. (US)
  • BD Biosciences (US)
  • Cell Cure Neuroscences Ltd. (Israel)
  • Cellular Dynamics International (US)
  • GE Healthcare (UK)
  • MilliporeSigma (US)
  • PerkinElmer, Inc. (US)
  • Reliance Life Sciences Ltd. (India)
  • Research & Diagnostics Systems, Inc. (US)
  • SABiosciences Corp. (US)
  • STEMCELL Technologies, Inc. (Canada)
  • Stemina Biomarker Discovery, Inc. (US)
  • Takara Bio, Inc. (Japan)
  • TATAA Biocenter AB (Sweden)
  • Thermo Fisher Scientific, Inc. (US)
  • UK Stem Cell Bank (UK)
  • ViaCyte, Inc. (US)
  • Vitrolife AB (Sweden)



Key Topics Covered:

1. Industry Overview


2. Regulatory Landscape

3. HESC Application And Clinical Trials

4. Competitive Landscape

5. Regional Market Overview

6. Recent Industry Activity

7. Global Market Perspective

For more information about this report visit http://www.researchandmarkets.com/research/99zn45/human_embryonic


[ Back To TMCnet.com's Homepage ]